2/2 NCCU-LCCC Partnership in Cancer Research
2/2 NCCU-LCCC 癌症研究合作伙伴关系
基本信息
- 批准号:9769511
- 负责人:
- 金额:$ 94.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-28 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmAdvisory CommitteesAfrican AmericanAmerican Cancer SocietyAttentionBiotechnologyCancer BiologyCancer BurdenCancer Research ProjectClinicalCollaborationsCommunity OutreachComplexComprehensive Cancer CenterDiseaseEducationEducation and OutreachEducational process of instructingEffectivenessEnvironmental ExposureEyeFacultyFoundationsFundingGeneticGenomicsGoalsGrantHealth PromotionHealth SciencesHealth Services AccessibilityHistopathologyHumanIncidenceInfrastructureInstitutionInterventionLeadershipMalignant NeoplasmsMentorshipMinorityMinority RecruitmentMolecularMorbidity - disease rateNational Cancer InstituteNorth CarolinaOutreach ResearchPathway interactionsPilot ProjectsPopulationPopulation SciencesPositioning AttributePredispositionPublic HealthRecurrenceResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch TrainingResourcesScientistSocioeconomic FactorsStudentsTissuesTrainingTreatment FailureU-Series Cooperative AgreementsUNC Lineberger Comprehensive Cancer CenterUnderrepresented StudentsUniversitiesanticancer researchbasecancer educationcancer health disparitycancer therapycareercaucasian Americancohortcommunity interventioneducation researchexperiencegraduate studenthealth disparityhealth equityinterestmemberminority communitiesminority healthminority studentminority undergraduatemortalityoutreachpopulation basedprogramspublic health relevancerecruitsenior facultytheoriestraining opportunitytranslational cancer researchtranslational scientistundergraduate student
项目摘要
DESCRIPTION (provided by applicant) Abstract: The North Carolina Central University (NCCU) and the Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina Chapel Hill (UNC-CH) will continue their effective and mutually beneficial partnership focusing on African-American health disparities. During the past 13 years NCI funding has firmly established the Partnership building on complementary institutional strengths, conducting molecular and population-based cancer research and training of junior faculty and students. This Comprehensive Partnership to Advance Cancer Health Equity (CPACHE) application builds upon the foundation already established through the previous U54 funding to meet the challenge of disparities in cancer incidence and mortality in North Carolina and the US through cancer research, education and community outreach. Our goals are to: (1) strengthen cancer research capacity at NCCU providing NCCU scientists mentorship and collaborative opportunities to compete for NCI grants; (2) enrich the capacity of NCCU and LCCC to further explore mechanisms underlying the disproportionate incidence of cancer mortality and morbidity between African Americans and Caucasian Americans, using both molecular and population-based approaches; (3) increase the number of NCCU scientists focused on cancer research as well as the education of minority undergraduate and graduate students in cancer research; (4) increase the faculty at the UNC LCCC focused on minority disparities research; and (5) create long-term collaborations between basic, public health, and translational scientists from NCCU and UNC LCCC. The strengths of each institution are uniquely positioned to overcome the weaknesses found in the other to achieve these priorities. Specific collaborative components of the proposal include: Two full and one pilot projects in community intervention and population science, one full and one pilot project in basic/translational cancer research in diseases with a higher incidence in African Americans, and 3 cores: Outreach, Research Education, and Histopathology. The partnership combines the expertise and resources of LCCC in population/public health sciences emphasizing disparities in North Carolina, genomics, cancer biology and cancer education and NCCU's demonstrated interest and faculty with minority health disparities research particularly in Durham NC, the state-funded NCCU units that allow faculty release from teaching and the emphasis on reaching minority populations and developing the careers of, faculty and students. These complementary institutional strengths will assure that the Partnership builds the infrastructure necessary for a lasting collaborative research, effective community outreach and a substantial contribution to our understanding of minority disparities.
描述(由申请人提供) 摘要:北卡罗莱纳中央大学 (NCCU) 和北卡罗莱纳大学教堂山分校 (UNC-CH) 的 Lineberger 综合癌症中心 (LCCC) 将继续开展有效和互利的合作伙伴关系,重点关注非洲-美国的健康差距。在过去的 13 年里,NCI 的资助牢固地建立了合作伙伴关系,建立在互补的机构优势、开展分子和人群癌症研究以及对初级教师和学生的培训的基础上。这一促进癌症健康公平的全面合作伙伴关系 (CPACHE) 申请建立在之前 U54 资助所建立的基础上,旨在通过癌症研究、教育和社区外展应对北卡罗来纳州和美国癌症发病率和死亡率差异的挑战。我们的目标是:(1) 加强 NCCU 的癌症研究能力,为 NCCU 科学家提供指导和合作机会,以竞争 NCI 资助; (2) 增强 NCCU 和 LCCC 的能力,利用分子和基于人口的方法,进一步探索非洲裔美国人和白人美国人之间癌症死亡率和发病率不成比例的机制; (3)增加国立政治大学专注于癌症研究的科学家数量以及少数民族本科生和研究生癌症研究的教育; (4) 增加北卡罗来纳大学 LCCC 专注于少数群体差异研究的师资队伍; (5) 在 NCCU 和 UNC LCCC 的基础科学家、公共卫生科学家和转化科学家之间建立长期合作。每个机构都具有独特的优势,能够克服对方的弱点,从而实现这些优先事项。该提案的具体合作组成部分包括:社区干预和人口科学方面的两个完整项目和一个试点项目,非裔美国人发病率较高疾病的基础/转化癌症研究的一个完整项目和一个试点项目,以及 3 个核心项目:外展、研究教育和组织病理学。该合作伙伴关系结合了 LCCC 在人口/公共卫生科学方面的专业知识和资源,强调北卡罗来纳州的差异、基因组学、癌症生物学和癌症教育,以及 NCCU 对少数族裔健康差异研究特别是在北卡罗来纳州达勒姆(NCCU 的国家资助单位)表现出的兴趣和教职人员这使得教师能够从教学中解放出来,并重点关注少数族裔群体和发展教师和学生的职业生涯。这些互补的机构优势将确保该伙伴关系建立必要的基础设施,以进行持久的合作研究、有效的社区外展以及对我们对少数族裔差异的理解做出重大贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H. Shelton Earp其他文献
Vanadate stimulates tyrosine phosphorylation of two proteins in Raji human lymphoblastoid cell membranes
钒酸盐刺激 Raji 人淋巴母细胞膜中两种蛋白质的酪氨酸磷酸化
- DOI:
- 发表时间:
1983 - 期刊:
- 影响因子:3.5
- 作者:
H. Shelton Earp;R. A. Rubin;K. Austin;R. Dy - 通讯作者:
R. Dy
Interactions between Two Cytoskeleton-associated Tyrosine Kinases: Calcium-dependent Tyrosine Kinase and Focal Adhesion Tyrosine Kinase*
两种细胞骨架相关酪氨酸激酶之间的相互作用:钙依赖性酪氨酸激酶和粘着斑酪氨酸激酶*
- DOI:
10.1074/jbc.274.13.8917 - 发表时间:
1999-03-26 - 期刊:
- 影响因子:0
- 作者:
Xiong Li;Ruth C. Dy;William G. Cance;Lee M. Graves;H. Shelton Earp - 通讯作者:
H. Shelton Earp
ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
ErbB4 剪接变体 Cyt1 和 Cyt2 有 16 个氨基酸不同,对体内乳腺上皮产生相反的影响
- DOI:
10.1128/mcb.01705-08 - 发表时间:
2009-07-13 - 期刊:
- 影响因子:5.3
- 作者:
K. Elenius;L. Chodosh;H. Shelton Earp;Iii Strunk;L. Miraglia;C. Husted;Debra M. Hunter;R. Muraoka;Melissa A. Sandahl;Karen E - 通讯作者:
Karen E
Inhibition of the Calcium-dependent Tyrosine Kinase (CADTK) Blocks Monocyte Spreading and Motility*
抑制钙依赖性酪氨酸激酶 (CADTK) 可阻止单核细胞扩散和运动*
- DOI:
10.1074/jbc.m006916200 - 发表时间:
2001-02-02 - 期刊:
- 影响因子:0
- 作者:
J. M. Watson;Timothy W. Harding;V. Golubovskaya;John S. Morris;Deborah Hunter;Xiong Li;J. Stephen Haskill;H. Shelton Earp - 通讯作者:
H. Shelton Earp
An Intracellular Calcium Signal Activates p70 but Not p90 Ribosomal S6 Kinase in Liver Epithelial Cells*
细胞内钙信号激活肝上皮细胞中的 p70 但不激活 p90 核糖体 S6 激酶*
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:4.8
- 作者:
Lee M. Graves;Yaqin He;J. Lambert;Deborah Hunter;Xiong Li;H. Shelton Earp - 通讯作者:
H. Shelton Earp
H. Shelton Earp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H. Shelton Earp', 18)}}的其他基金
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis
MerTK、Tyro3 和 Axl 在胰腺癌和转移中的不同作用
- 批准号:
10601958 - 财政年份:2022
- 资助金额:
$ 94.38万 - 项目类别:
MerTK and the Innate Immune Response to Melanoma
MerTK 和对黑色素瘤的先天免疫反应
- 批准号:
9231607 - 财政年份:2017
- 资助金额:
$ 94.38万 - 项目类别:
Ack1: Activation and Consequences in Prostate Cancer
Ack1:前列腺癌中的激活和后果
- 批准号:
8270330 - 财政年份:2011
- 资助金额:
$ 94.38万 - 项目类别:
Ack1: Activation and Consequences in Prostate Cancer
Ack1:前列腺癌中的激活和后果
- 批准号:
8193120 - 财政年份:2011
- 资助金额:
$ 94.38万 - 项目类别:
NCCU-LCCC Partnership in Cancer Research (2 of 2)
NCCU-LCCC 癌症研究合作伙伴关系(2 of 2)
- 批准号:
8726939 - 财政年份:2010
- 资助金额:
$ 94.38万 - 项目类别:
相似海外基金
BCM-TSU CURED Administration Core (AC)
BCM-TSU CURED 管理核心 (AC)
- 批准号:
10762266 - 财政年份:2023
- 资助金额:
$ 94.38万 - 项目类别:
Therapeutic targeting of RTK protein granules in cancer
RTK 蛋白颗粒在癌症中的治疗靶向
- 批准号:
10591331 - 财政年份:2023
- 资助金额:
$ 94.38万 - 项目类别:
BCM/TSU P20 Collaborative Union for Cancer Research, Education and Disparities (CURED) Administrative Core (AC)
BCM/TSU P20 癌症研究、教育和差异合作联盟 (CURED) 行政核心 (AC)
- 批准号:
10762046 - 财政年份:2023
- 资助金额:
$ 94.38万 - 项目类别: